SINGAPORE - Health data analytics start-up BioFourmis said Thursday it has received US$1 million (S$1.34 million) in funding from investors SpesNet and Eden Strategy.

BioFourmis specialises in offering predictive and precise insights into personal health.

"Our vision is to empower people by making personalised healthcare data understandable and actionable through cutting-edge technology," founder and chief executive of BioFourmis Mr Kuldeep Singh said. "Our product Biovitals .. interprets and fuses healthcare data from almost any source, creating highly optimised monitoring solutions and accurate health predictions," he added.

Biovitals is an analytics engine that uses cognitive technology and advanced machine learning to provide insights into personal health.

The data can be used by medical institutions, nutritionists, care givers or corporate executives.